Breaking news

Cypriot Passport Ranks 13th Globally for Travel Freedom

The Cypriot passport has achieved an impressive 13th position in the global ranking for travel freedom, according to the latest report by Henley & Partners, an esteemed firm specialising in global citizenship and residence advisory. This notable ranking reflects the strength and versatility of the Cypriot passport, granting its holders extensive travel privileges worldwide.

The Henley Passport Index, which assesses the travel access provided by different nations’ passports, has placed Cyprus in this prestigious position based on the number of destinations its citizens can visit without a prior visa. As of the latest update, Cypriot passport holders enjoy visa-free or visa-on-arrival access to 178 countries and territories, underscoring the significant mobility and convenience afforded by Cypriot citizenship.

This achievement is a testament to Cyprus’s robust diplomatic relationships and its standing within the international community. The country’s EU membership plays a pivotal role in this high ranking, facilitating visa-free travel across the Schengen Area and numerous other countries. Additionally, Cyprus’s bilateral agreements and participation in various international organisations further enhance its passport’s global reach.

The high ranking of the Cypriot passport is particularly advantageous for business professionals, frequent travellers, and those seeking international opportunities. It enables seamless travel for business, tourism, and personal purposes, reducing the administrative burden and costs associated with visa applications. This ease of travel is a significant asset for Cypriots, fostering greater global mobility and connectivity.

Moreover, the strength of the Cypriot passport contributes positively to the country’s attractiveness as a destination for foreign investors and expatriates. The ability to travel freely to a wide array of countries is a compelling factor for individuals considering Cyprus as a base for business or residence. This aspect enhances the island’s reputation as a favourable location for international business operations and high-net-worth individuals seeking global mobility.

The rise of the Cypriot passport in the Henley Passport Index also reflects the ongoing efforts by the Cypriot government to bolster its international ties and enhance the nation’s global standing. Diplomatic initiatives, economic agreements, and collaborative efforts with other countries have played a crucial role in expanding the travel freedoms enjoyed by Cypriot citizens.

In addition to the practical benefits, the ranking is a source of national pride, highlighting Cyprus’s successful navigation of global diplomatic and economic landscapes. It underscores the island’s commitment to maintaining strong international relations and ensuring that its citizens can enjoy the benefits of extensive travel access.

Despite its high ranking, the Cypriot government continues to work towards further enhancing the passport’s strength. Ongoing negotiations and efforts to establish new visa-waiver agreements aim to expand the list of accessible destinations, ensuring that Cypriot passport holders can enjoy even greater travel freedoms in the future.

Cyprus’ MammoCheck Wins Top Honour At NBG Business Seeds Competition

Cyprus-based medical technology startup MammoCheck has won first place at the 16th NBG Business Seeds Innovation and Technology Competition, emerging as the overall winner from 344 entries submitted from Greece, Cyprus and other countries.

The annual competition, organised by the National Bank of Greece, announced the results during an awards ceremony in Athens. MammoCheck received the competition’s top distinction along with a €20,000 cash prize.

Founded in 2024 as a spin-out from Frederick University, MammoCheck is developing an artificial intelligence-powered Software as a Medical Device (SaMD) platform designed to support breast cancer screening. The solution combines a smartphone application with low-cost thermal cameras to provide an adjunctive screening tool powered by AI.

The company says its technology aims to address a significant gap in breast cancer screening, with hundreds of millions of women worldwide lacking regular access to mammography, including many women under the age of 45 who are not covered by most national screening programmes.

“We are honoured to receive first place among 344 entries from Greece, Cyprus and abroad. This recognition reflects the dedication of our team, our clinical partners and the women who inspire our work every day,”

said Alexandra Dimitriadou, co-founder and CEO of MammoCheck.

MammoCheck is currently conducting a clinical trial across multiple hospital sites as it advances toward FDA 510(k) clearance in the United States and CE marking under the European Union’s Medical Device Regulation (MDR).

The latest award marks another milestone for Cyprus’ growing health technology ecosystem, highlighting the increasing international visibility of locally developed medical innovations.

eCredo
The Future Forbes Realty Global Properties
Uol
Aretilaw firm

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter